Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2018 Jan 9;92(2):390–398. doi: 10.1002/ccd.27478

Table 3.

Outcomes of SAVR According to Pre-Operative Risk Assessment

Low-risk
(n=565)
Intermediate-
risk (n=309)
High-risk
(n=175)
P
value
Death at 30 days 7 (1.2%) 21 (6.8%) 22 (12.6%) <0.01
Estimated mortality 2.3% 5.5% 14 % <0.01
Observed/Expected (O/E) mortality 0.52 1.23 0.9 NA
Stroke 16 (2.8%) 13 (4.2%) 15 (8.6%) 0.01
Myocardial infarction 4 (0.7%) 7 (2.3%) 7 (4%) 0.02
Reoperation for bleeding 20 (3.5%) 21 (6.8%) 11 (6.3%) 0.07
Renal failure 5 (0.9%) 4 (1.3%) 6 (3.4%) 0.07
Cardiac arrest 8 (1.3%) 12 (4.1%) 14 (4.7%) <0.01
Mechanical ventilation > 48 hours 26 (4.6%) 41 (13.3%) 41 (23.4%) <0.01
Tracheostomy 0 (0%) 3 (1.4%) 3 (2.4%) <0.01
Any complication 8.6% 24% 33% <0.01
Length of stay – mean (±SD) 9 (6) 15 (18) 19 (15) <0.01